Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
1998-12-24
2004-04-06
McGarry, Sean (Department: 1635)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S070100, C435S325000, C435S375000, C536S023100
Reexamination Certificate
active
06716600
ABSTRACT:
BACKGROUND OF THE INVENTION
(1) Field of the Invention
This invention relates generally to trophic or growth factors and, more particularly, to novel growth factors of the neurturin-GDNF family of growth factors.
(2) Description of the Related Art
The development and maintenance of tissues in complex organisms requires precise control over the processes of cell proliferation, differentiation, survival and function. A major mechanism whereby these processes are controlled is through the actions of polypeptides known as “growth factors”. These structurally diverse molecules act through specific cell surface receptors to produce these actions.
Growth factors, termed “neurotrophic factors” promote the differentiation, growth and survival of neurons and reside in the nervous system or in innervated tissues. Nerve growth factor (NGF) was the first neurotrophic factor to be identified and characterized (Levi-Montalcini et al.,
J. Exp. Zool
. 116:321, 1951 which is incorporated by reference). NGF exists as a non-covalently bound homodimer that promotes the survival and growth of sympathetic, neural crest-derived sensory, and basal forebrain cholinergic neurons. In sympathetic neurons this substance produces neurite outgrowth in vitro and increased axonal and dendritic growth in vivo. (See Levi-Montalcini and Booker,
Proc Nat'l Acad Sci
46:384-391, 1960; Johnson et al.
Science
210: 916-918, 1980; Crowley et al.,
Cell
76:1001-12, 1994 which are incorporated by reference). NGF has effects on cognition and neuronal plasticity, and can promote the survival of neurons that have suffered damage due to a variety of mechanical, chemical, viral, and immunological insults (Snider and Johnson,
Ann Neurol
26:489-506, 1989; Hefti,
J Neurobiol
25:1418-35, 1994 which are incorporated by reference). NGF also is known to extensively interact with the endocrine system and in immune and inflammatory processes. (Reviewed in Scully and Otten,
Cell Biol Int
19:459-469, 1995; Otten and Gadient,
Int. J Devl Neurosci
13:147-151, 1995 which are incorporated by reference). For example, NGF promotes the survival of mast cells. (Horigome et al.
J Biol Chem
269:2695-2707, 1994 which is incorporated by reference).
In recent years it has become apparent that growth factors fall into classes, i.e. families or superfamilies based upon the similarities in their amino acid sequences. These families include, for example, the fibroblast growth factor family, the neurotrophin family and the transforming growth factor-beta (TGF-&bgr;) family. As an example of family member sequence similarities, TGF-&bgr; family members have 7 canonical framework cysteine residues which identify members of this superfamily.
NGF is the prototype of such a family of growth factors. Brain-derived neurotrophic factor (BDNF), the second member of this family to be discovered, was shown to be related to NGF by virtue of the conservation of all six cysteines that form the three internal disulfides of the NGF monomer (Barde,
Prog Growth Factor Res
2:237-248, 1990 and Liebrock et al.
Nature
341:149-152, 1989 which are incorporated by reference). By utilizing the information provided by BDNF of the highly conserved portions of two factors, additional members (NT-3, NT-4/5) of this neurotrophin family were rapidly found by several groups (Klein,
FASEB J
8:738-44, 1994 which is incorporated by reference).
Neurotrophic factors structurally unrelated to NGF have been recently identified. These include factors originally isolated based upon a “neurotrophic action” such as ciliary neurotrophic factor (CNTF) (Lin et al.,
Science
246:1023-5, 1989 which is incorporated by reference) along with others originally isolated as a result of non-neuronal activities (e.g. fibroblast growth factors (Cheng and Mattson
Neuron
1:1031-41,1991 which is incorporated by reference), IGF-I (Kanje et al,
Brain Res
486:396-398, 1989 which is incorporated by reference) leukemia inhibitory factor (Kotzbauer et al,
Neuron
12:763-773, 1994 which is incorporated by reference).
Glial-derived neurotrophic factor (GDNF), is one such neurotrophic factor structurally unrelated to NGF.
GDNF was, thus, a unique factor, which, up until now, was not known to be a member of any subfamily of factors. The discovery, purification and cloning of GDNF resulted from a search for factors crucial to the survival of midbrain dopaminergic neurons, which degenerate in Parkinson's disease. GDNF was purified from rat B49 glial cell conditioned media (Lin et al.,
Science
260:1130-2, 1993 which is incorporated by reference). Sequence analysis revealed it to be a distant member of the TGF-&bgr; superfamily of growth factors, having approximately 20% identity based primarily on the characteristic alignment of the 7 canonical framework cysteine residues (Lin et al.,
Science
260:1130-2, 1993 which is incorporated by reference). Thus, GDNF could possibly have represented a new subfamily within the TGF-&bgr; superfamily.
Recombinant GDNF produced in bacteria specifically promotes the survival and morphological differentiation of dopaminergic neurons (Lin et al.,
Science
260:1130-2, 1993); Tomac et al.,
Nature
373:335-9, 1995; Beck et al.,
Nature
373:339-41, 1995 and Ebendal et al.,
J Neurosci Res
40:276-84, 1995 which are incorporated by reference) and motor neurons (Henderson et al.,
Science
266:1062-4, 1994; Yan et al.,
Nature
373:341-4, 1995; and Oppenheim et al.,
Nature
373:344-6, 1995 which are incorporated by reference). Overall, GDNF was a more potent factor for promoting the survival of motor neurons than the other factors, and it was the only factor that prevented neuronal atrophy in response to these lesions, thereby positioning it as a promising therapeutic agent for motor neuron diseases.
It is now generally believed that neurotrophic factors regulate many aspects of neuronal function, including survival and development in fetal life, and structural integrity and plasticity in adulthood. Since both acute nervous system injuries as well as chronic neurodegenerative diseases are characterized by structural damage and, possibly, by disease-induced apoptosis, it is likely that neurotrophic factors play some role in these afflictions. Indeed, a considerable body of evidence suggests that neurotrophic factors may be valuable therapeutic agents for treatment of these neurodegenerative conditions, which are perhaps the most socially and economically destructive diseases now afflicting our society. Nevertheless, because different neurotrophic factors can potentially act preferentially through different receptors and on different neuronal or non-neuronal cell types, there remains a continuing need for the identification of new members of neurotrophic factor families for use in the diagnosis and treatment of a variety of acute and chronic diseases of the nervous system.
SUMMARY OF THE INVENTION
Briefly, therefore, the present invention is directed to the identification and isolation of substantially purified factors that promote the survival and growth of neurons as well as non-neuronal cells. Accordingly, the inventors herein have succeeded in discovering novel protein growth factors belonging to a family of growth factors for which GDNF was the first known member. The first such newly discovered family member was neurturin and this is the subject of copending application Ser. No. 08/519,777. Based upon the sequence of GDNF and neurturin the inventors herein have discovered another member of the GDNF-Neurturin family of growth factors referenced herein as persephin (PSP). This growth factor is believed to show at least 75% sequence identity among homologous sequences from different mammalian species although sequence homology may be as low as 65% in non-mammalian species such as avian species. Indeed, the mouse, rat and human mature persephin sequences show from about 80% to about 94% sequence identity. Mature persephin proteins identified herein comprise mouse sequences as set forth in SEQ ID NOS:79 and 187 (
FIG. 17B
amino acids 66 through 154 and 61
DeSauvage Fred
Johnson Eugene M.
Klein Robert
Kotzbauer Paul T.
Lampe Patricia A.
Epps Ford Janet L.
McGarry Sean
Thompson & Coburn LLP
Washington University
LandOfFree
Persephin and related growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Persephin and related growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Persephin and related growth factors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3208342